Published in Onco Targets Ther on March 23, 2017
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 21.53
Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77
Genomic analysis of metastasis reveals an essential role for RhoC. Nature (2000) 10.11
siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov (2004) 4.73
CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res (2004) 4.53
Rho GTPases in cancer cell biology. FEBS Lett (2008) 4.47
RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev (2005) 2.59
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer (1998) 2.48
RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res (2000) 2.48
Epidemiology of inflammatory breast cancer (IBC). Breast Dis (2006) 2.46
Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin (2010) 2.45
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther (2005) 1.95
The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol Cell Biol (2006) 1.59
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget (2014) 1.28
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer (2004) 1.24
RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res (2006) 1.19
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis (2002) 1.10
Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One (2009) 1.07
Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer (2005) 1.05
KAI1 tetraspanin and metastasis suppressor. Int J Biochem Cell Biol (2005) 1.03
Future prospect of RNA interference for cancer therapies. Curr Drug Targets (2010) 1.01
Concepts in in vivo siRNA delivery for cancer therapy. J Cell Physiol (2009) 0.98
Gene silencing with siRNA duplexes composed of target-mRNA-complementary and partially palindromic or partially complementary single-stranded siRNAs. RNA Biol (2006) 0.97
The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells. Med Oncol (2011) 0.85